GORMAN KEVIN CHARLES

CIK 00012010962 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001201096

Recent Transactions

50 trades

Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2025-08-07−106,322→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-08-07$126.41/sh−106,322→ 514,596 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-08-07$35.99/sh+106,322→ 620,918 total
Sale
Xencor Inc$XNCR
Common Stock
2025-06-16$9.22/sh−3,173→ 18,905 total
Award
Xencor Inc$XNCR
Stock Option (Right to Buy)
2025-06-12+27,372→ 27,372 total
Award
Xencor Inc$XNCR
Common Stock
2025-06-12+13,686→ 22,078 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-05-27$120.38/sh−9,613→ 514,596 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2025-05-21+6,610→ 6,610 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13$116.68/sh−3,012→ 524,209 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13$116.69/sh−2,832→ 521,618 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-13−5,376→ 10,754 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13+5,603→ 527,221 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-13−5,603→ 16,812 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13+5,376→ 524,450 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-10$118.37/sh−2,274→ 519,074 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-08+4,318→ 521,348 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-08−4,318→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-31$152.92/sh−2,707→ 517,030 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-31+5,141→ 519,737 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-01-31−5,141→ 5,142 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2025-01-27−146,105→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-27$149.46/sh−146,105→ 514,596 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-27$32.99/sh+146,105→ 660,701 total
Sale
Xencor Inc$XNCR
Common Stock
2024-09-27$20.68/sh−2,654→ 8,392 total
Award
Xencor Inc$XNCR
Stock Option (Right to Buy)
2024-06-13+11,971→ 11,971 total
Award
Xencor Inc$XNCR
Common Stock
2024-06-13+5,986→ 11,046 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2024-02-13+22,415→ 22,415 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2024-02-13+112,644→ 112,644 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-13$133.02/sh−2,832→ 514,596 total
Purchase
Xencor Inc$XNCR
Common Stock
2024-02-13$19.12/sh+53→ 5,060 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Incentive Stock Option
2024-02-13$43.24/sh−2,312→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Incentive Stock Option
2024-02-13$35.99/sh−2,778→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-13$43.24/sh+2,312→ 512,052 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-13$35.99/sh+2,778→ 509,740 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-08$134.15/sh−2,274→ 506,962 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-06$142.18/sh−3,040→ 504,919 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-01-31$140.69/sh−2,707→ 502,188 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-01-09$19.59/sh−62,023→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-01-09$134.01/sh−62,023→ 499,754 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-01-09$19.59/sh+62,023→ 561,777 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-01-08$19.59/sh−105,835→ 62,023 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-01-08$132.44/sh−105,835→ 499,754 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-01-08$19.59/sh+105,835→ 605,589 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-08-21$107.40/sh−9,328→ 499,754 total
Award
Xencor Inc$XNCR
Common Stock
2023-06-20+5,007→ 5,007 total
Award
Xencor Inc$XNCR
Stock Option (Right to Buy)
2023-06-20+10,013→ 10,013 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2023-02-13+21,506→ 21,506 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2023-02-13+133,656→ 133,656 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-02-08$104.30/sh−2,274→ 491,365 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-02-07$102.30/sh−3,248→ 470,930 total

Companies

Recent Filings

Address

NEUROCRINE BIOSCIENCES, INC. 12780 EL CAMINO REAL

SAN DIEGO, CA, 92130

View on SEC.gov